Aptevo Therapeutics Inc. Proceeds from Long-Term Debt Issued
Aptevo Therapeutics Inc. (APVO) reported Proceeds from Long-Term Debt Issued of $20.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2017-11-13
- Aptevo Therapeutics Inc. proceeds from issuance of long-term debt for the quarter ending 2016-12-31 was $1.96M.
- Aptevo Therapeutics Inc. proceeds from issuance of long-term debt for fiscal 2016 was $20.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2016-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $20.00M 10-K · filed 2017-03-31 | |
| 2016-09-30 | $18.04M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |